HRP20041160A2 - Novel combination for the treatment of airway disorders - Google Patents
Novel combination for the treatment of airway disordersInfo
- Publication number
- HRP20041160A2 HRP20041160A2 HR20041160A HRP20041160A HRP20041160A2 HR P20041160 A2 HRP20041160 A2 HR P20041160A2 HR 20041160 A HR20041160 A HR 20041160A HR P20041160 A HRP20041160 A HR P20041160A HR P20041160 A2 HRP20041160 A2 HR P20041160A2
- Authority
- HR
- Croatia
- Prior art keywords
- treatment
- novel combination
- airway disorders
- airway
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02010305 | 2002-05-07 | ||
| PCT/EP2003/004653 WO2003094967A2 (en) | 2002-05-07 | 2003-05-03 | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20041160A2 true HRP20041160A2 (en) | 2005-08-31 |
Family
ID=29414673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20041160A HRP20041160A2 (en) | 2002-05-07 | 2003-05-03 | Novel combination for the treatment of airway disorders |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20050222193A1 (sr) |
| EP (1) | EP1506016A2 (sr) |
| JP (1) | JP2005528418A (sr) |
| KR (1) | KR20050007476A (sr) |
| CN (1) | CN1652822A (sr) |
| AU (1) | AU2003227710A1 (sr) |
| BR (1) | BR0309808A (sr) |
| CA (1) | CA2484272A1 (sr) |
| EA (1) | EA200401454A1 (sr) |
| HR (1) | HRP20041160A2 (sr) |
| IL (1) | IL164755A0 (sr) |
| MX (1) | MXPA04011018A (sr) |
| NO (1) | NO20045343L (sr) |
| PL (1) | PL373287A1 (sr) |
| RS (1) | RS95304A (sr) |
| WO (1) | WO2003094967A2 (sr) |
| ZA (1) | ZA200407896B (sr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2467652A1 (en) * | 2001-11-19 | 2003-05-30 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
| SE0303451D0 (sv) * | 2003-12-18 | 2003-12-18 | Astrazeneca Ab | New compounds |
| US20070179364A1 (en) * | 2004-04-30 | 2007-08-02 | Altana Pharma Ag | Method of classifying gerd |
| CA2582300A1 (en) * | 2004-10-05 | 2006-04-13 | Altana Pharma Ag | Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient |
| ES2677668T3 (es) | 2010-11-16 | 2018-08-06 | Texas Heart Institute | Agonistas que mejoran la unión de células que expresan integrina a receptores de integrina |
| KR101873530B1 (ko) * | 2012-04-10 | 2018-07-02 | 삼성전자주식회사 | 모바일 기기, 모바일 기기의 입력 처리 방법, 및 모바일 기기를 이용한 전자 결제 방법 |
| JO3737B1 (ar) * | 2015-07-21 | 2021-01-31 | Athenex Therapeutics Ltd | تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| DE59410119D1 (de) * | 1993-07-02 | 2002-06-20 | Byk Gulden Lomberg Chem Fab | Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren |
| DE19541689A1 (de) * | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
| PL184060B1 (pl) * | 1995-01-27 | 2002-08-30 | Rhone Poulenc Rorer Ltd | Podstawione związki fenylowe do zastosowania jako środki antagonistyczne endoteliny |
| ES2247604T3 (es) * | 1995-06-12 | 2006-03-01 | G.D. SEARLE & CO. | Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa. |
| AU7095296A (en) * | 1995-09-26 | 1997-04-17 | Takeda Chemical Industries Ltd. | Phosphorylamides, their preparation and use |
| SE9603725D0 (sv) * | 1996-10-11 | 1996-10-11 | Astra Ab | New teatment |
| US6380222B2 (en) * | 1996-10-11 | 2002-04-30 | Astrazeneca Ab | Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| WO1999004816A1 (en) * | 1997-07-25 | 1999-02-04 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Proton pump inhibitor in therapeutic combination with antibacterial substances |
| US6060472A (en) * | 1998-04-06 | 2000-05-09 | Apotex Inc. | Thiadiazole compounds useful as inhibitors of H+ /K+ atpase |
| BR9913152A (pt) * | 1998-08-26 | 2001-05-15 | Smithkline Beecham Corp | Terapias para tratamento de doenças pulmonares |
| US6436953B1 (en) * | 1998-09-23 | 2002-08-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
| GB9911017D0 (en) * | 1999-05-13 | 1999-07-14 | Zeneca Ltd | Pharmaceutical compositions |
| SK286850B6 (sk) * | 2000-03-29 | 2009-06-05 | Altana Pharma Ag | Prekurzory imidazopyridínových derivátov, farmaceutický prostriedok s ich obsahom a ich použitie |
| DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US6528527B2 (en) * | 2000-11-07 | 2003-03-04 | Merck & Co., Inc. | Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist |
| CA2467652A1 (en) * | 2001-11-19 | 2003-05-30 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
-
2003
- 2003-05-03 RS YU95304A patent/RS95304A/sr unknown
- 2003-05-03 KR KR10-2004-7017820A patent/KR20050007476A/ko not_active Withdrawn
- 2003-05-03 EP EP03725140A patent/EP1506016A2/en not_active Withdrawn
- 2003-05-03 BR BR0309808-7A patent/BR0309808A/pt not_active IP Right Cessation
- 2003-05-03 WO PCT/EP2003/004653 patent/WO2003094967A2/en not_active Ceased
- 2003-05-03 CN CNA038104008A patent/CN1652822A/zh active Pending
- 2003-05-03 CA CA002484272A patent/CA2484272A1/en not_active Abandoned
- 2003-05-03 AU AU2003227710A patent/AU2003227710A1/en not_active Abandoned
- 2003-05-03 HR HR20041160A patent/HRP20041160A2/xx not_active Application Discontinuation
- 2003-05-03 US US10/513,598 patent/US20050222193A1/en not_active Abandoned
- 2003-05-03 JP JP2004503050A patent/JP2005528418A/ja active Pending
- 2003-05-03 EA EA200401454A patent/EA200401454A1/ru unknown
- 2003-05-03 MX MXPA04011018A patent/MXPA04011018A/es unknown
- 2003-05-03 PL PL03373287A patent/PL373287A1/xx not_active Application Discontinuation
-
2004
- 2004-09-30 ZA ZA200407896A patent/ZA200407896B/en unknown
- 2004-10-21 IL IL16475504A patent/IL164755A0/xx unknown
- 2004-12-06 NO NO20045343A patent/NO20045343L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL164755A0 (en) | 2005-12-18 |
| BR0309808A (pt) | 2005-03-01 |
| CN1652822A (zh) | 2005-08-10 |
| NO20045343L (no) | 2004-12-06 |
| RS95304A (sr) | 2006-12-15 |
| EA200401454A1 (ru) | 2005-06-30 |
| ZA200407896B (en) | 2006-06-28 |
| PL373287A1 (en) | 2005-08-22 |
| JP2005528418A (ja) | 2005-09-22 |
| MXPA04011018A (es) | 2005-01-25 |
| KR20050007476A (ko) | 2005-01-18 |
| CA2484272A1 (en) | 2003-11-20 |
| WO2003094967A3 (en) | 2004-04-01 |
| EP1506016A2 (en) | 2005-02-16 |
| US20050222193A1 (en) | 2005-10-06 |
| WO2003094967A2 (en) | 2003-11-20 |
| AU2003227710A1 (en) | 2003-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL372425A1 (en) | Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders | |
| AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
| IL209842A0 (en) | Compounds for the treatment of metabolic disorders | |
| PL1656346T3 (pl) | 1,2,3,4-Tetrapodstawiony indol do leczenia chorób dróg oddechowych | |
| ZA200401004B (en) | Combination for the treatment of inflammatory disorders | |
| SI1556342T1 (sl) | Fenetanolaminski derivat za zdravljenje respiratornih bolezni | |
| AU2003233583A1 (en) | Oral lactoferrin in the treatment of respiratory disorders | |
| ZA200504558B (en) | Compounds for the treatment of metabolic disorders | |
| PL378108A1 (pl) | Leczenie łączone do terapii zapalnych zaburzeń immunologicznych | |
| AU2003274342A8 (en) | Compositions for the treatment of autoimmune disorders | |
| IL162485A0 (en) | Compounds for the treatment of inflammatory disorders | |
| SI1530466T1 (sl) | Uporaba nintedaniba za zdravljenje pljučne fibroze | |
| AU2003228819A8 (en) | Combinations for the treatment of inflammatory skin disorders | |
| AU2003286728A8 (en) | Compounds for the treatment of metabolic disorders | |
| IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
| IL163871A0 (en) | Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders | |
| IL168065A0 (en) | Herbal medicine containing cyclodextrins for the treatment of ear disorders | |
| HRP20041160A2 (en) | Novel combination for the treatment of airway disorders | |
| AU2003205898A1 (en) | Combination therapy for respiratory disorders | |
| AU2003294100A8 (en) | Use of hyaluronic acid for respiratory disorders or the upper airways | |
| ZA200505996B (en) | Combination therapy for the treatment of immunoinflammatory disorders | |
| HRP20041159A2 (en) | Combination for the treatment of airway disorders | |
| GB2388027B (en) | Use of palatinose for the treatment of mental stress | |
| GB0201025D0 (en) | The treatment of degenerative diseases | |
| AU2003274885A1 (en) | Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080429 Year of fee payment: 6 |
|
| OBST | Application withdrawn |